Biocomputation and the Analysis of Complex Data Sets in Nutritional Genomics

Nutritional Genomics: Discovering the Path to Personalized Nutrition

Volumn , Issue , 2006, Pages 375-401

  Dawson, Kevin ^a   Rodriguez, Raymond L ^a   Hawkes, Wayne Chris ^a   Malyj, Wasyl ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biocomputation and complex data set analysis; Data sets in nutritional genomics; Diet gene interactions

Indexed keywords

EID: 34247099699     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0471781797.ch17     Document Type: Chapter

References (59)

1. J. Kaput and R. L. Rodriguez (2004). Nutritional genomics: The next frontier in the postgenomic era, Physiol. Genomics 16:166-177.
2. R. M. DeBusk, C. P. Fogarty, J. M. Ordovas, and K. S. Kornman (2005). Nutritional genomics in practice: Where do we begin? J. Am. Diet. Assoc. 105:589-598.
3. J. M. Ordovas and V. Mooser (2004). Nutrigenomics and nutrigenetics, Curr. Opin. Lipidol. 15:101-108.
4. C. Buning, H. Schmidt, H. Lochs, and J. Ockenga (2004). Genetic components of lactose intolerance and community frequency, J. Bone Miner. Res. 19:1746; author reply 1747.
5. L. J. Spaapen and M. E. Rubio-Gozalbo (2003). Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency, state of the art, Mol. Genet. Metab. 78:93-99.
6. M. Suzuki, C. West, and E. Beutler (2001). Large-scale molecular screening for galactosemia alleles in a pan-ethnic population, Hum. Genet. 109:210-215.
7. M. Haapalahti, P. Kulmala, T. J. Karttunen, et al. (2005). Nutritional status in adolescents and young adults with screen-detected celiac disease, J. Pediatr. Gastroenterol. Nutr. 40:566-570.
8. G. Miltiadous, M. Cariolou, and M. Elisaf (2004). Genetic polymorphisms affecting the phenotypic expression of patients with molecularly defined familial hypercholesterolaemia, Atherosclerosis 177:217.
9. C. G. Bell, A. J. Walley, and P. Froguel (2005). The genetics of human obesity, Nat. Rev. Genet. 6:221-234.
10. I. Barroso (2005). Genetics of Type 2 diabetes, Diabet. Med. 22:517-535.
11. C. C. Wang, M. L. Goalstone, and B. Draznin (2004). Molecular mechanisms of insulin resistance that impact cardiovascular biology, Diabetes 53:2735-2740.
12. F. Cambien (2005). Coronary heart disease and polymorphisms in genes affecting lipid metabolism and inflammation, Curr. Atheroscler. Rep. 7:188-195.
13. C. B. Ambrosone, S. E. McCann, J. L. Freudenheim, et al. (2004). Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype, J. Nutr. 134:1134-1138.
14. J. L. Chin and R. E. Reiter (2004). Molecular markers and prostate cancer prognosis, Clin. Prostate Cancer 3:157-164.
15. K. Huppi and G. V. Chandramouli (2004). Molecular profiling of prostate cancer, Curr. Urol. Rep. 5:45-51.
16. V. M. Adhami, N. Ahmad, and H. Mukhtar (2003). Molecular targets for green tea in prostate cancer prevention, J. Nutr. 133:2417S-2424S.
17. J. L. Ashurst and J. E. Collins (2003). Gene annotation: Prediction and testing, Annu. Rev. Genomics Hum. Genet. 4:69-88.
18. F. S. Collins, M. S. Guyer, and A. Charkravarti (1997). Variations on a theme: cataloging human DNA sequence variation, Science 278:1580-1581.
19. G. D. Schuler, M. S. Boguski, E. A. Stewart, et al. (1996). A gene map of the human genome, Science 274:540-546.
20. A. Persidis (1998). Proteomics, Nat. Biotechnol. 16:393-394.
21. M. J. Geisow (1998). Proteomics: One small step for a digital computer, one giant leap for humankind, Nat. Biotechnol. 16:206.
22. L. M. Raamsdonk, B. Teusink, D. Broadhurst, et al. (2001). A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations, Nat. Biotechnol. 19:45-50.
23. E. C. Butcher, E. L. Berg, and E. J. Kunkel (2004). Systems biology in drug discovery, Nat. Biotechnol. 22:1253-1259.
24. Annonymous (2004). Arrays come to age, Genome Technol. 42:38-39.
25. T. R. Golub, D. K. Slonim, P. Tamayo, et al. (1999). Molecular classification of cancer: class discovery and class prediction by gene expression monitoring, Science 286:531-537.
26. U. Palaniappan, R. I. Cue, H. Payette, and K. Gray-Donald (2003). Implications of dayto- day variability on measurements of usual food and nutrient intakes, J. Nutr. 133:232-235.
27. K. O. Sarri, M. K. Linardakis, F. N. Bervanaki, N. E. Tzanakis, and A. G. Kafatos (2004). Greek Orthodox fasting rituals: A hidden characteristic of the Mediterranean diet of Crete, Br. J. Nutr. 92:277-284.
28. R. Roky, I. Houti, S. Moussamih, S. Qotbi, and N. Aadil (2004). Physiological and chronobiological changes during Ramadan intermittent fasting, Ann. Nutr. Metab. 48:296-303.
29. A. Wiser, E. Maymon, M. Mazor, et al. (1997). Effect of the Yom Kippur fast on parturition, Harefuah 132:745-824.
30. M. Kuokkanen, N. S. Enattah, A. Oksanen, et al. (2003). Transcriptional regulation of the lactase-phlorizin hydrolase gene by polymorphisms associated with adult-type hypolactasia, Gut 52:647-652.
31. L. Perusse, T. Rankinen, A. Zuberi, et al. (2005). The human obesity gene map: The 2004 update, Obesity Res. 13:381-490.
32. A. Marti, M. J. Moreno-Aliaga, J. Hebebrand, and J. A. Martinez (2004). Genes, lifestyles and obesity, Int. J. Obesity-Relat. Metab. Disorders 28(Suppl 3):S29-S36.
33. R. Nielsen (2004). Population genetic analysis of ascertained SNP data, Hum. Genomics 1:218-224.
34. S. H. Jung, H. Bang, and S. Young (2005). Sample size calculation for multiple testing in microarray data analysis, Biostatistics 6:157-169.
35. F. Gao, B. C. Foat, and H. J. Bussemaker (2004). Defining transcriptional networks through integrative modeling of mRNA expression and transcription factor binding data, BMC Bioinformatics 5:31.
36. J. B. Tenenbaum, V. de Silva, and J. C. Langford (2000). A global geometric framework for nonlinear dimensionality reduction, Science 290:2319-2323.
37. S. T. Roweis and L. K. Saul (2000). Nonlinear dimensionality reduction by locally linear embedding, Science 290:2323-2326.
38. D. L. Donoho and K. Grimes (2003). Hessian Eigenmaps: New Locally Linear Embedding Techniques for High-Dimensional Data. Department of Statistics, Stanford University, Stanford, CA, pp. 1-15.
39. G. A. Thorisson and L. D. Stein (2003). The SNP Consortium website: Past, present and future, Nucleic Acids Res. 31:124-127.
40. M. Belkin and P. Niyogi (2003). Laplacian eigenmaps for dimensionality reduction and data representation, Neural Comput. 15:1373-1396.
41. L. M. Bruce, C. H. Koger, and J. Li (2002). Dimensionality reduction of hyperspectral data using discrete wavelet transform feature extraction, IEEE Trans. Geosci. Remote Sensing 40:2331-2337.
42. W. S. DeSarbo, A. M. Degeratu, M. Wedel, and M. K. Saxton (2001). The spatial representation of market information, Market. Sci. 20:426-441.
43. K. Z. Mao (2005). Identifying critical variables of principal components for unsupervised feature selection, IEEE Trans. Syst. Man Cybern. Part B Cybern. 35:339-344.
44. Y. Tan, L. Shi, W. Tong, and C. Wang (2005). Multi-class cancer classification by total principal component regression (TPCR) using microarray gene expression data, Nucleic Acids Res. 33:56-65.
45. L. Liu, D. M. Hawkins, S. Ghosh, and S. S. Young (2003). Robust singular value decomposition analysis of microarray data, Proc. Natl. Acad. Sci. U.S.A. 100:13167-13172.
46. Y. H. Taguchi and Y. Oono (2005). Relational patterns of gene expression via non-metric multidimensional scaling analysis, Bioinformatics 21:730-740.
47. M. A. Mendez, C. Hodar, C. Vulpe, M. Gonzalez, and V. Cambiazo (2002). Discriminant analysis to evaluate clustering of gene expression data, FEBS Lett. 522:24-28.
48. J. Wang, J. Delabie, H. Aasheim, E. Smeland, and O. Myklebost (2002). Clustering of the SOM easily reveals distinct gene expression patterns: Results of a reanalysis of lymphoma study, BMC Bioinformatics 3:36.
49. E. Hubbell, W. M. Liu, and R. Mei (2002). Robust estimators for expression analysis, Bioinformatics 18:1585-1592.
50. C. Li and W. Hung Wong (2001). Model-based analysis of oligonucleotide arrays: Model validation, design issues and standard error application, Genome Biol. 2: RESEARCH0032.
51. C. Li and W. H. Wong (2001). Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection, Proc. Natl. Acad. Sci. U.S.A. 98:31-36.
52. R. A. Irizarry, B. Hobbs, F. Collin, et al. (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data, Biostatistics 4:249-264.
53. W. M. Liu, R. Mei, X. Di, et al. (2002). Analysis of high density expression microarrays with signed-rank call algorithms, Bioinformatics 18:1593-1599.
54. B. M. Bolstad, R. A. Irizarry, M. Astrand, and T. P. Speed (2003). A comparison of normalization methods for high density oligonucleotide array data based on variance and bias, Bioinformatics 19:185-193.
55. R. S. Parrish and H. J. Spencer, (2004). Effect of normalization on significance testing for oligonucleotide microarrays, J. Biopharm. Stat. 14:575-589.
56. B. Rosati, F. Grau, A. Kuehler, S. Rodriguez, and D. McKinnon (2004). Comparison of different probe-level analysis techniques for oligonucleotide microarrays, Biotechniques 36:316-322.
57. P. Szaniszlo, N. Wang, M. Sinha, et al. (2004). Getting the right cells to the array: gene expression microarray analysis of cell mixtures and sorted cells, Cytometry Part A 59:191-202.
58. D. de Ridder, C. E. van der Linden, T. Schonewille, et al. (2005). Purity for clarity: the need for purification of tumor cells in DNA microarray studies, Leukemia 19:618-627.
59. K. Dawson, R. L. Rodriguez, and W. Malyj (2005). Sample phenotype clusters in highdensity oligonucleotide microarray data sets are revealed using isomap, a nonlinear algorithm, BMC Bioinformatics 6:195.